Lilly Bussmann

Head of Strategic Capital at Oxford Science Enterprises

Greater Oxford Area

Overview

Lilly Bussmann is the Head of Strategic Capital at Oxford Science Enterprises, overseeing investments in Series A and Seed stages within the BioTech sector. With a career spanning roles at prominent firms like RT Partners and Oxford Sciences Innovation, she brings a wealth of experience in investment and strategic capital management to her current position at Oxford Science Enterprises.

Work Experience

Oxford Science Enterprises

Head of Strategic Capital
2021 - Current
Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational companies via its unique partnership with Oxford University, the world’s #1 research university. From company formation, seed to Series C+. OSE's portfolio covers deep tech, health tech and biotech. Past investments include: Base Genomics (Exact Sciences) Yasa Motors (Mercedes) LatentLogic (Waymo) PepGen (Nasdaq) Barinthus (Nasdaq) Semantic Technologies (Samsung)